Is there a generic for Meloxicam?

Yes. The FDA Orange Book lists 25 approved generic (ANDA) applications for Meloxicam, referencing the brand XIFYRM. Generics rated with an "A" therapeutic-equivalence code are considered substitutable for the brand.

What is the reference-listed drug for Meloxicam?

XIFYRM (NDA 218395, AZURITY) is the reference-listed drug, the approved product a generic applicant must show its version is the same as.

What patents protect Meloxicam?

The Orange Book lists 11 patents against Meloxicam products, with the earliest listed expiry in 2030. Listed patents cover the drug substance, drug product, or approved methods of use, and a generic launching before they expire must file a Paragraph IV certification.

What dosage forms of Meloxicam are approved?

Meloxicam is approved in the following dosage forms: capsule, solution, suspension, tablet, tablet, orally disintegrating.

FDA Orange Book · active-ingredient family

Meloxicam

Meloxicam: 7 brands, 25 generics; first approved Apr 13, 2000; generic available.

Generic availableHas discontinued products

Generic status & protection

Generic available: 25 ANDA applications approved.

Earliest patent expiry May 26, 2030

Brands (NDA)

Generics (ANDA)

Listed patents

Next patent expiry

May 26, 2030

in 3 yr 8 mo

Brand (NDA) products

Originator applications

XIFYRMRLDRS
AZURITYNDA 2183952025
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
30MG/ML (30MG/ML) SOLUTION INTRAVENOUS Rx —
QAMZOVARLDRS
NANJING DELOVANDA 2175932025
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
30MG/ML (30MG/ML) SOLUTION INTRAVENOUS Rx —
ANJESORLD
BAUDAXNDA 2105832020
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
30MG/ML (30MG/ML) SOLUTION INTRAVENOUS Discontinued —
QMIIZ ODTRLD
TERSERANDA 21121020182 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET, ORALLY DISINTEGRATING ORAL Discontinued —
15MG TABLET, ORALLY DISINTEGRATING ORAL Discontinued —
VIVLODEXRLD
ICEUTICA OPERATIONSNDA 20723320152 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
5MG CAPSULE ORAL Discontinued —
10MG CAPSULE ORAL Discontinued —
MELOXICAMRLDRS
AVONDALE PHARMSNDA 0215302004
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG/5ML SUSPENSION ORAL Rx —
MOBICRLD
BOEHRINGER INGELHEIMNDA 02093820002 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
30MG/ML (30MG/ML)	SOLUTION	INTRAVENOUS	Rx	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
30MG/ML (30MG/ML)	SOLUTION	INTRAVENOUS	Rx	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
30MG/ML (30MG/ML)	SOLUTION	INTRAVENOUS	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET, ORALLY DISINTEGRATING	ORAL	Discontinued	—
15MG	TABLET, ORALLY DISINTEGRATING	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
5MG	CAPSULE	ORAL	Discontinued	—
10MG	CAPSULE	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG/5ML	SUSPENSION	ORAL	Rx	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Generic (ANDA) products (25)

Abbreviated applications

MELOXICAM
ASCENT PHARMS INCANDA 21757920232 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
NOVITIUM PHARMAANDA 21139820212 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
5MG CAPSULE ORAL Rx AB
10MG CAPSULE ORAL Rx AB
MELOXICAM
LUPINANDA 20948720202 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
5MG CAPSULE ORAL Rx AB
10MG CAPSULE ORAL Rx AB
MELOXICAM
NOVITIUM PHARMAANDA 07792820092 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
UNICHEMANDA 07792720062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
CR DOUBLE CRANEANDA 07803920062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
YUNG SHIN PHARMANDA 07791820062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
TAROANDA 07810220062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
AUROBINDO PHARMAANDA 07800820062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
RISINGANDA 07793120062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
COREPHARMAANDA 07788220062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
MYLANANDA 07793420062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
AIPING PHARM INCANDA 07792020062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
CHARTWELL RXANDA 07793620062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
CIPLAANDA 07792920062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
GLENMARK PHARMS LTDANDA 07793220062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
IMPAX LABS INCANDA 07793020062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
LUPIN PHARMSANDA 07794420062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
NATCO PHARMAANDA 07792320062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
PURACAP PHARMANDA 07793820062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB
MELOXICAM
ROXANEANDA 07792520062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
SUN PHARM INDS INCANDA 07793720062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
TP ANDA HOLDINGSANDA 07793520062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
ZENNOVAANDA 07793320062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Discontinued —
15MG TABLET ORAL Discontinued —
MELOXICAM
ZYDUS PHARMS USAANDA 07792120062 strengths
Approved strengths under this FDA application.
Strength Dosage form Route Status TE
7.5MG TABLET ORAL Rx AB
15MG TABLET ORAL Rx AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
5MG	CAPSULE	ORAL	Rx	AB
10MG	CAPSULE	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
5MG	CAPSULE	ORAL	Rx	AB
10MG	CAPSULE	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Discontinued	—
15MG	TABLET	ORAL	Discontinued	—

Approved strengths under this FDA application.
Strength	Dosage form	Route	Status	TE
7.5MG	TABLET	ORAL	Rx	AB
15MG	TABLET	ORAL	Rx	AB

Patent & exclusivity timeline

Protection horizon

Patent expiryExclusivity endToday

Listed patents

Orange Book patent file

Patents listed in the FDA Orange Book for this product, with expiration date and patent type.
Patent	Expires	In	Type
10709713	May 26, 2030	in 3 yr 8 mo	U-2750
11253478	May 26, 2030	in 3 yr 8 mo	ProductU-3318
9974746	May 26, 2030	in 3 yr 8 mo	Product
8545879	Aug 31, 2030	in 3 yr 11 mo	Product
9526734	Mar 31, 2033	in 6 yr 7 mo	Product
9808468	Mar 31, 2035	in 8 yr 7 mo	U-2165
9649318	Mar 31, 2035	in 8 yr 7 mo	Product
11458145	Mar 08, 2039	in 12 yr 7 mo	U-3318
10881663	Mar 08, 2039	in 12 yr 7 mo	U-3038
12059423	Jul 19, 2040	in 14 yr	SubstanceProduct
12263176	Jul 31, 2041	in 15 yr	Product

Approval history

FDA approval span

First approval

Apr 13, 2000

26 yr 10 mo ago

Most recent approval

Jun 05, 2025

1 yr 4 mo ago

Approvals span 2000–2025 across 32 FDA applications.

Brand (NDA) 722%

Generic (ANDA) 2578%

Meloxicam: frequently asked questions

Generics, reference-listed drug, patents, and exclusivity for this active ingredient, from the FDA Orange Book.

Built directly from the FDA Orange Book data file (products, patents, and exclusivity). TE codes, RLD/RS flags, patent expirations, and exclusivity dates match the official FDA record. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.

Related FDA reference tools

Your Next Submission Could Take 6+ Fewer Weeks and Cost $250K Less.

Book a Demo